[DOI] [PubMed] [Google Scholar] 2.Lane TF, Iruela-Arispe ML, Johnson RS, et al
503A pharmacy source matters: The before and after results we see at our clinic come from pharmaceutical-grade 503A compounded BPC-157
You can find much more detailed information about the downtime of each of these treatments by clicking on their titles above and visiting their information pages on our website
In some embodiments, the formulations described herein have a pH and/or practical osmolarity as described herein, and have a concentration of active pharmaceutical ingredient from about 0.0001% to about 60%, from about 0.001% to about 40%, from about 0.01% to about 20%, from about 0.01% to about 10%, from about 0.01% to about 7.5%, from about 0.01% to about 6%, from about 0.01 to about 5%, from about 0.1 to about 10%, or from about 0.1 to about 6% of the active ingredient by weight of the formulation